FDA clears Gyrus' RF (radio frequency) generator:
This article was originally published in Clinica
Executive Summary
Gyrus has received US FDA 510(k) clearance for its G1 temperature-controlled radio frequency generator for powering the firm's single-patient-use surgical instruments for treating upper airway obstructions, including sleep apnoea, nasal obstructions and habitual snoring. The unit addresses a market opportunity valued in excess of $1 billion in the US alone, says the Reading, UK firm.